These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 555597

  • 1. Simultaneous use of rapidly absorbed and sustained release theophylline preparations in children.
    Hein EW, Domson JF, Sheen A, Buffone GJ, Sly RM.
    Ann Allergy; 1979 Oct; 43(4):217-9. PubMed ID: 555597
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Theolair SR and Theo-Dur tablets.
    Domson JF, Hein EW, Sheen A, Sly RM.
    Ann Allergy; 1979 Oct; 43(4):220-2. PubMed ID: 555598
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics.
    Utama I, Kreukniet J, Meering PG, Maes RA.
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):287-91. PubMed ID: 6885202
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of Nuelin-SR 250 mg in asthmatic children: a new sustained-release theophylline.
    Mitchell EA, Liang AY.
    N Z Med J; 1980 Aug 13; 92(665):91-3. PubMed ID: 6933343
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic properties of sustained-release theophylline (Theolair-SR) in relation to timing of doses after low-fat meals.
    Welsh PW, O'Connell EJ, Sachs MI, Moyer TP, Wick KA, Harrison LI, McCarville SE, Kvam DC.
    Ann Allergy; 1989 May 13; 62(5):396-400. PubMed ID: 2719348
    [Abstract] [Full Text] [Related]

  • 6. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM, Weinstein DB, Watts MT, Seifert B.
    Clin Ther; 1986 May 13; 8(2):175-80. PubMed ID: 3698064
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS, Robertson C, Correia J, Isles AF, Levison H, Macleod SM.
    Ann Allergy; 1986 Feb 13; 56(2):133-7. PubMed ID: 3946845
    [Abstract] [Full Text] [Related]

  • 8. Steady-state evaluation of two controlled-release theophylline preparations in children.
    Tinkelman DG, Lutz CN, Crummie A, Harrison LI, McCarville SE, Bastyr MH.
    J Asthma; 1988 Feb 13; 25(1):27-31. PubMed ID: 3053601
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP, Drost RH, Kreukniet J, Maes RA.
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug 13; 22(8):423-9. PubMed ID: 6490224
    [Abstract] [Full Text] [Related]

  • 10. Sustained release theophylline for the forgetful asthmatic.
    Weinstein AG.
    Ann Allergy; 1985 Oct 13; 55(4):563-7. PubMed ID: 4051262
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S, Laver J, Benson L, Cotariu D, Neli P, Saidman JL, Viure E.
    Isr J Med Sci; 1982 Feb 13; 18(2):255-8. PubMed ID: 7068356
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum theophylline concentrations in asthmatic children.
    Sheen A, Sly RM.
    Ann Allergy; 1978 Dec 13; 41(6):327-9. PubMed ID: 727568
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A, Businco E, Businco L, Solano A, Calabretta C.
    Allergol Immunopathol (Madr); 1983 Dec 13; 11(1):11-4. PubMed ID: 6858803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
    McKenzie S, Baillie E.
    J Int Med Res; 1979 Dec 13; 7 Suppl 1():22-7. PubMed ID: 437305
    [Abstract] [Full Text] [Related]

  • 19. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R, Kelly HW, Howick J, McWilliams BC.
    Am J Dis Child; 1983 May 13; 137(5):469-73. PubMed ID: 6846276
    [Abstract] [Full Text] [Related]

  • 20. Optimal time for obtaining peak and trough theophylline levels in 12-hour and 24-hour products in children.
    Tinkelman DG, Lutz CN, Miller E, Cole WQ.
    Ann Allergy; 1987 Mar 13; 58(3):190-2. PubMed ID: 3826771
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.